Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Am J Surg. 2022 May 13;224(3):990–998. doi: 10.1016/j.amjsurg.2022.05.001

Table 4.

Comparison of balance between a propensity score matched cohort of nonrecovered potential and actual donation after cardiac death liver donors using more liberal criteria to define non-recovered potential donors. Standardized differences greater than 0.1 in absolute value are considered significant and highlighted in bold.

Non-Recovered Potential DCDs (n = 245) Actual DCDs (n = 245) Standardized Difference

Age 48.0 (34.0–55.0) 46.0 (37.0–54.0) −0.02
Male Gender 179 (73.1%) 181 (73.9%) −0.02
Height 175.3 (168.0–182.0) 175.0 (168.0–182.9) −0.05
Weight 81.2 (71.1–95.0) 80.7 (70.7–92.3) −0.05
BMI 26.9 (23.6–31.0) 26.3 (23.5–30.7) −0.05
AST 43.0 (28.0–58.0) 36.0 (25.0–51.0) 0.07
ALT 33.0 (20.0–46.0) 28.0 (18.0–40.0) 0.09
Total Bilirubin 0.5 (0.3–0.7) 0.5 (0.3–0.7) 0.03
Diabetes 26 (10.6%) 27 (11.0%) −0.01
Ethinicity
Caucasian 203 (82.9%) 197 (80.4%) 0.06
African American 16 (6.5%) 17 (6.9%) −0.02
Hispanic 20 (8.2%) 22 (9.0%) −0.03
Asian 2 (0.8%) 2 (0.8%) 0.00
Native American/Other 4 (1.6%) 7 (2.9%) −0.08
ABO
A 92 (37.6%) 98 (40.0%) −0.05
AB 10 (4.1%) 8 (3.3%) 0.04
B 37 (15.1%) 36 (14.7%) 0.01
O 106 (43.3%) 103 (42.0%) 0.02
Cause of Death
Anoxia 115 (46.9%) 116 (47.4%) −0.01
CVA 51 (20.8%) 55 (22.5%) −0.04
Trauma 63 (25.7%) 56 (22.9%) 0.07
Other 16 (6.5%) 18 (7.4%) −0.03
IV Drug Use 45 (18.4%) 41 (16.7%) 0.04
Withdrawal to Crossclamp Interval (minutes) 24.0 (20.0–27.0) 23.0 (19.0–27.0) −0.03
HIV NAT
Negative 236 (96.3%) 234 (95.5%) 0.04
Not Done 2 (0.8%) 1 (0.4%) 0.05
Prior to Routine Collection 7 (2.9%) 10 (4.1%) −0.07
Hepatitis C NAT
Positive 21 (8.6%) 17 (6.9%) 0.06
Negative 217 (88.6%) 218 (89.0%) −0.01
Prior to Routine Collection 7 (2.9%) 10 (4.1%) −0.07
Hepatitis C Serology Positive 32 (13.1%) 24 (9.8%) 0.10
Heavy Alcohol Use
Yes 76 (31.0%) 73 (29.8%) 0.03
No 163 (66.5%) 165 (67.4%) −0.02
Unknown 6 (2.5%) 7 (2.9%) −0.03